Anti-fibrotic activity of Irbesartan in chronic hepatitis with hypertension using Elastography
Not Applicable
- Conditions
- chronic hepatitis with hypertension
- Registration Number
- JPRN-UMIN000002707
- Lead Sponsor
- Graduate School of Medicine, Osaka City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patient is treated with RAS drugs prior to onset of this study. 2. Patient has a hepatocarcinoma. 3. Patient has a hypersensitivity to Irbesartan. 4. Patient is pregnant, or may become pregnant. 5. In the opinion of the investigator, patient is unsuitable as a study subject.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method liver fibrosis
- Secondary Outcome Measures
Name Time Method